16 December 2019
From next year budding New Zealand startups will have even stronger support to help turn technology and science into
Four tech incubators have been selected for a new Technology Incubator programme, and a new HealthTech Activator
initiative is being introduced, Vic Crone, CEO of Callaghan Innovation announced today.
“There are significant opportunities to turn more of New Zealand’s advanced technologies into successful businesses.
Many of these technologies start out at our universities and we want to see them thrive,” says Ms Crone.
Under a new and improved Technology Incubator programme launching in April 2020, deep tech startups will have access to
four incubators, up from three in the pilot, as well as higher repayable loan amounts of up to $750,000. The programme
is boosted by funding allocated in Budget 2019 along with an additional $9 million funding announced in September.
The four tech incubators announced today will ensure this IP makes it out of the lab, and starts creating high value
exports and jobs. These incubators – currently in contract negotiations are:
- Brandon Capital Partners
- WNT Ventures
- Bridgewest Ventures.
“Innovators need the right support in the early phases of their business development, and we want to grow that
capability in the ecosystem,” said Ms Crone.
“Our tech incubators will provide Kiwi innovators with a fantastic breadth of commercialisation support, international
and local connections, and access to investment. In addition to this there is specific expertise available for sectors
of strategic importance to New Zealand, including agrifood and life sciences.”
Ms Crone says: “There are also opportunities for New Zealand to create more successful healthtech startups, but there is
a wider need to pull together support across the sector, which has more complex, expensive and riskier paths to
“A new HealthTech Activator run by Callaghan Innovation, working alongside CMDT and MedTech CoRE, will coordinate
healthtech support resources and data across the ecosystem. The idea is to speed up the journey of healthtech startups
by better connecting, demystifying commercial avenues and reducing risks,” adds Ms Crone.
The HealthTech Activator initiative has been allocated $2 million over four years to cover staffing, operational costs
and programme support. While the Activator support services will be virtually accessible across the nation, Callaghan
Innovation anticipates establishing two physical nodes to provide a location for early stage healthtech companies to
network, hot desk or co-locate for short periods.
Further information on the HealthTech Activator will be available in the new year and for more information on the
Technology Incubator programme visit Callaghan Innovation’s website
Editor’s notes on current Incubators
The pilot programme achieved some great results with the foundational tech incubators, including 45 new deep tech
startups, attracting significant investments, and creating new high-value tech jobs. However, the new RFP was highly
competitive and unfortunately current incubators, Astrolab and Powerhouse, were not successful in their bids to deliver
the new programme. Callaghan Innovation is working with the incubators on their transition out of the programme and to
help ensure any ventures still in incubation are supported appropriately.
About the 2020 Tech Incubators
Bridgewest Ventures is part of the Bridgewest Group
(“Bridgewest”), a US-based investment company, which also operates a Technology Incubator in San Diego, California.
Bridgewest has been successful in its ability to incubate and launch major global innovation-led companies and intends
to leverage this experience to replicate the same successful model in New Zealand. Bridgewest’s deep technology
experience is wide-ranging and includes biotechnology, agri-tech, pharmaceuticals, UAV technology, IoT and
semiconductor, AI and software development, as well as drug discovery and deep research into health technology. It
intends to leverage its connections, international reach, and commercialisation experience to transform New Zealand
opportunities into world-class companies.
Deep-tech incubator, WNT Ventures
, was created in 2014 through a collaboration with experienced entrepreneurs and institutional capital providers. Its
key mission is to support the commercialisation of complex technology by sourcing, investing in and incubating high
growth early stage businesses with global potential. WNT has interests in sustainability, agritech and food, artificial
intelligence, medtech, engineering, sensing and industrial automation. During the pilot technology incubator programme,
WNT has raised and invested two funds totalling $7.8 million and alongside Callaghan Innovation have invested in 14
companies throughout New Zealand.
Brandon Capital Partners
Brandon Capital Partners
(Brandon), established in 2007, is a leading life science venture capital firm with a New Zealand and Australian
presence. As a life science technology incubator, Brandon will curate and seed promising life sciences research
discoveries, providing access to capital, expertise and hands-on training to support the next generation of New Zealand
life science companies. With networks and capacity generated through the Medical Research Commercialisation Fund (MRCF),
and with staff in NZ, Australia, USA and the UK, it brings a strong international perspective. Brandon has over $700
million in funds under management with the capacity to provide significant funding to support ideas through to
is an existing Callaghan Innovation-funded business accelerator based in Palmerston North and has been working with
agrifood tech start-ups since 2014. Its focus is investment in technologies that improve the efficiency and
sustainability of food production and distribution. As a newly appointed Callaghan Technology Incubator, Sprout will
extend its activities to provide emerging agritech and future food start-ups with a pathway to global markets and
international investment networks. Sprout’s technology incubator has a mix of international, local and sector-focused
investors including Gallagher, Fonterra, Finistere Ventures and OurCrowd.